These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36344511)

  • 21. Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA.
    Gemble S; Ahuja A; Buhagiar-Labarchède G; Onclercq-Delic R; Dairou J; Biard DS; Lambert S; Lopes M; Amor-Guéret M
    PLoS Genet; 2015 Jul; 11(7):e1005384. PubMed ID: 26181065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine.
    Tohda H; Nagao M; Sugimura T; Oikawa A
    Mutat Res; 1993 Oct; 289(2):275-80. PubMed ID: 7690896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of PARP inhibitor sensitivity and resistance.
    D'Andrea AD
    DNA Repair (Amst); 2018 Nov; 71():172-176. PubMed ID: 30177437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
    Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
    Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of sister chromatid exchange by 3-aminobenzamide is independent of bromodeoxyuridine.
    Morgan WF; Wolff S
    Cytogenet Cell Genet; 1984; 38(1):34-8. PubMed ID: 6705564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of sister chromatid exchanges at common fragile sites.
    Glover TW; Stein CK
    Am J Hum Genet; 1987 Nov; 41(5):882-90. PubMed ID: 3674017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
    Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
    J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
    Talens F; Jalving M; Gietema JA; Van Vugt MA
    Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
    Gottipati P; Vischioni B; Schultz N; Solomons J; Bryant HE; Djureinovic T; Issaeva N; Sleeth K; Sharma RA; Helleday T
    Cancer Res; 2010 Jul; 70(13):5389-98. PubMed ID: 20551068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.
    Mukhopadhyay A; Elattar A; Cerbinskaite A; Wilkinson SJ; Drew Y; Kyle S; Los G; Hostomsky Z; Edmondson RJ; Curtin NJ
    Clin Cancer Res; 2010 Apr; 16(8):2344-51. PubMed ID: 20371688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sister chromatid exchanges occur in G2-irradiated cells.
    Conrad S; Künzel J; Löbrich M
    Cell Cycle; 2011 Jan; 10(2):222-8. PubMed ID: 21224723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
    Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
    Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.
    Kim MK; Zitzmann S; Westermann F; Arnold K; Brouwers S; Schwab M; Savelyeva L
    Cancer Lett; 2004 Jul; 210(1):85-94. PubMed ID: 15172125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.
    Amin O; Beauchamp MC; Nader PA; Laskov I; Iqbal S; Philip CA; Yasmeen A; Gotlieb WH
    BMC Cancer; 2015 Oct; 15():817. PubMed ID: 26510816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of 3-aminobenzamide-mediated increases in spontaneous and induced SCEs.
    Schwartz JL; Weichselbaum RR
    Basic Life Sci; 1984; 29 Pt A():293-304. PubMed ID: 6442569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccharomyces cerevisiae rad51 mutants are defective in DNA damage-associated sister chromatid exchanges but exhibit increased rates of homology-directed translocations.
    Fasullo M; Giallanza P; Dong Z; Cera C; Bennett T
    Genetics; 2001 Jul; 158(3):959-72. PubMed ID: 11454747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction.
    Kaina B; Aurich O
    Mutat Res; 1985 May; 149(3):451-61. PubMed ID: 3990696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers.
    Watkins JA; Irshad S; Grigoriadis A; Tutt AN
    Breast Cancer Res; 2014 Jun; 16(3):211. PubMed ID: 25093514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
    Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
    J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk of DNA double-strand break repair pathways in poly(ADP-ribose) polymerase inhibitor treatment of breast cancer susceptibility gene 1/2-mutated cancer.
    Sunada S; Nakanishi A; Miki Y
    Cancer Sci; 2018 Apr; 109(4):893-899. PubMed ID: 29427345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.